Perrigo is a major supplier of store-brand and private-label over-the-counter medicines, self-care products, and related consumer healthcare items sold mainly through retail chains. It develops and manufactures products that compete with national brands at lower prices, spanning pain relief, cough and cold, digestive health, infant nutrition, and personal care. Its model centers on scale manufacturing, retailer partnerships, and regulatory expertise rather than heavily advertised proprietary brands.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 1,056.3 | — | -8.4 | — |
| Q3 2025 | 1,043.3 | — | 7.5 | — |
| Q4 2025 | 1,109.6 | — | -1,418.1 | — |
| Q1 2026 | 969.2 | — | -398.6 | — |
| Q2 2026 | 1,022.8 | -3.2% | 74.5 | — |
All markets — KeepWinning global stock screener
Other companies on NYSE: Kohl's Corporation (KSS), Blackstone Digital Infrastructure Trust Inc. (BXDC), Getty Realty Corp. (GTY), Alamo Group Inc. (ALG), Genesis Energy, L.P. (GEL), The Gorman-Rupp Company (GRC)